MSTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 13 cases where MSTH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for MSTH just turned positive on December 13, 2024. Looking at past instances where MSTH's MACD turned positive, the stock continued to rise in of 14 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on MSTH as a result. In of 30 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
MSTH moved below its 50-day moving average on November 13, 2024 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MSTH crossed bearishly below the 50-day moving average on November 19, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Aroon Indicator for MSTH entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (57.958). P/E Ratio (0.000) is within average values for comparable stocks, (89.727). MSTH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (19.472).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MSTH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MSTH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MDOEX | 10.58 | 0.05 | +0.47% |
Morgan Stanley Developing Opportunity I | |||
BLYYX | 38.99 | -0.19 | -0.48% |
American Beacon Man Lg Cp Growth Y | |||
AFNIX | 26.72 | -0.19 | -0.71% |
Bahl & Gaynor Income Growth I | |||
WFEIX | 61.37 | -0.59 | -0.95% |
Allspring Mid Cap Growth Fund - Cl Inst | |||
OTIIX | 58.51 | -0.66 | -1.12% |
T. Rowe Price Small-Cap Stock I |
A.I.dvisor indicates that over the last year, MSTH has been loosely correlated with APNHF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MSTH jumps, then APNHF could also see price increases.
Ticker / NAME | Correlation To MSTH | 1D Price Change % | ||
---|---|---|---|---|
MSTH | 100% | N/A | ||
APNHF - MSTH | 35% Loosely correlated | N/A | ||
SFOSF - MSTH | 21% Poorly correlated | N/A | ||
GEDSF - MSTH | 20% Poorly correlated | N/A | ||
HTSUY - MSTH | 12% Poorly correlated | N/A | ||
FLGC - MSTH | 9% Poorly correlated | -4.92% | ||
More |
Ticker / NAME | Correlation To MSTH | 1D Price Change % |
---|---|---|
MSTH | 100% | N/A |
Pharmaceuticals: Other industry (226 stocks) | 6% Poorly correlated | -1.49% |
Pharmaceuticals industry (308 stocks) | 5% Poorly correlated | -1.42% |